Stocktoria

Stereotaxis, Inc. STXS

NYSE American · XASE · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2004-08-12

Stereotaxis, Inc. statistics & valuation

Market cap$169.1M
P / S5.2×
P / B12.5×
Net margin-66.8%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin52.7%54.2%55.5%65.6%66.3%71.2%78.8%80.5%65.5%76.6%
Operating margin-68.3%-91.9%-81.6%-66.7%-36.8%-25.2%-16.7%-8.4%-19.0%-20.0%
Net margin-66.8%-89.3%-77.4%-65.0%-30.6%-25.0%-15.9%0.4%-18.9%-16.4%
Return on assets-41.4%-51.5%-49.4%-34.2%-17.6%-12.0%-10.5%0.6%-55.2%-25.2%
Return on equity-160.5%-395.5%-126.7%-69.4%-31.7%-19.2%-20.2%8.9%22.2%24.6%
Debt / equity0.03×
Current ratio1.511.222.513.033.873.883.191.760.330.54

Source: SEC EDGAR filings · CIK 0001289340 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.